Phoebe Mounts
Insider
First SEC filing: Jan. 13, 2021 · Latest: Jan. 13, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 14, 2023 | CRMD | A | 125,000 | · | · | 125,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 18, 2022 | CRMD | A | 140,000 | · | · | 140,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 1, 2021 | CRMD | A | None | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 11, 2021 | CRMD | A | 140,000 | · | · | 140,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 13, 2020 | CRMD | P | 2,525 | $4.03 | $10,176 | 7,200 Direct | +54.01% | Acquired | 78.4% (price as of 2026-10-02) |
| May 11, 2020 | CRMD | A | 50,000 | $4.08 | $204,000 | 50,000 Direct | · | Acquired | 76.2% (price as of 2026-10-02) |
| May 11, 2020 | CRMD | A | 50,000 | $5.63 | $281,500 | 50,000 Direct | · | Acquired | 27.7% (price as of 2026-10-02) |
| March 18, 2020 | CRMD | P | 3,250 | $3.05 | $9,912 | 4,675 Direct | +228.07% | Acquired | 135.7% (price as of 2026-10-02) |
| Feb. 25, 2020 | CRMD | A | 24,764 | $5.63 | $139,421 | 24,764 Direct | · | Acquired | 27.7% (price as of 2026-10-02) |
| Dec. 30, 2019 | CRMD | P | 1,425 | $7.04 | $10,032 | 1,425 Direct | · | Acquired | 2.1% (price as of 2026-10-02) |
| May 1, 2019 | CRMD | A | 70,000 | · | · | 70,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 14, 2023 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $4.43 | Jan. 14, 2033 | 125,000 | Acquired |
| Feb. 18, 2022 | CRMD | Stock Option (Right to Buy) | Common Stock | $4.03 | Feb. 18, 2032 | 140,000 | Acquired |
| Nov. 1, 2021 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $5.56 | Nov. 1, 2031 | · | Acquired |
| Jan. 11, 2021 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $8.32 | Jan. 11, 2031 | 140,000 | Acquired |
| May 11, 2020 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $4.08 | May 11, 2030 | 50,000 | Acquired |
| May 11, 2020 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $5.63 | May 11, 2030 | 50,000 | Acquired |
| Feb. 25, 2020 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $5.63 | Feb. 25, 2030 | 24,764 | Acquired |
| May 1, 2019 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock | $7.92 | May 1, 2029 | 70,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $375,000 | $61,875 | · | $1,164,810 | · | · | $11,412 | $1,613,097 |
| 2020 | $350,000 | · | · | $408,070 | $163,333 | · | $9,745 | $931,148 |
| 2019 | $232,885 | · | · | $426,790 | $84,000 | · | $2,479 | $746,154 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.